Heartflow, Inc. Common Stock (HTFL) Stock
Key stats
- Market cap
- $5.14B
- Price / Earnings ratio
- -41.0x
- EPS (TTM)
- -$0.24
- Volume
- Loading
- 52-week high
- $60.56
- 52-week low
- $20.13
Source: third-party data provider, as of November 13, 2026
Compare with HTFL
Recent news

HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High
HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High
HTFL

HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High
HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High
HTFL

HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?
HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?
HTFL

Why Heartflow Stock Soared Today
Why Heartflow Stock Soared Today
HTFL
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 60.26
- MACD 12/26/9
- 1.53
- EMA 9 of MACD
- 1.71
- MACD histogram
- -0.18
- SMA 50
- $51.74
- Price above SMA 50
- EMA 50
- $51.06
- Price above EMA 50
- SMA 200
- $34.98
- Price above SMA 200
- EMA 200
- $38.57
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 7 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High
HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High
HTFL

HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High
HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High
HTFL

HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?
HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?
HTFL

Why Heartflow Stock Soared Today
Why Heartflow Stock Soared Today
HTFL

This AI-Tied IPO Stock Just Broke Out On Its 'Outsized' Guidance Boost
This AI-Tied IPO Stock Just Broke Out On Its 'Outsized' Guidance Boost
HTFL

Heartflow Q2 Earnings Call Highlights
Heartflow Q2 Earnings Call Highlights
HTFL

HeartFlow (HTFL) Reports Q2 Loss, Beats Revenue Estimates
HeartFlow (HTFL) Reports Q2 Loss, Beats Revenue Estimates
HTFL

What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors?
What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors?
HTFL

Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?
HTFL

Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
HTFL
News tone: automated (AI) classification of the article's content, not a price prediction.
About Heartflow, Inc. Common Stock
No description available.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. John C.M. Farquhar | President, CEO & Director | 1973 |
| Mr. Vikram Verghese C.F.A. | Chief Financial Officer | 1985 |
| Dr. Campbell D.K. Rogers FACC, M.D. | Chief Medical Officer & Executive VP | 1961 |
| Dr. John Henry Stevens M.D. | Co-Founder | 1961 |
| Ms. Kathleen Carey | Senior Vice President of Operations | — |
| Mhairi L. Jones | Chief Accounting Officer | — |
| Mr. Justin Cambra | Chief Technology Officer | — |
| Mr. Nicholas S. Laudico | Vice President of Investor Relations | — |
| Ms. Angela Ahmad J.D. | Chief Legal & Compliance Officer | — |
| Mr. Shivanth Bhaskaran | Chief Commercial Operations & Customer Success Officer | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 60.26
- MACD 12/26/9
- 1.53
- EMA 9 of MACD
- 1.71
- MACD histogram
- -0.18
- SMA 50
- $51.74
- Price above SMA 50
- EMA 50
- $51.06
- Price above EMA 50
- SMA 200
- $34.98
- Price above SMA 200
- EMA 200
- $38.57
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
7 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $39.00
- Average
- $49.14
- High
- $64.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +9.6 | +8.0 | +3.5 | -5.3 | -3.3 | |||||||
| 2026 | +3.1 | -19.5 | +1.2 | +21.5 | +8.1 | -5.4 | -17.8 | +88.3 | -1.3 | +20.7 | +2.4 |



